Combined Analysis of CSF Tau Levels and [(123)I]Iodoamphetamine SPECT in Mild Cognitive Impairment: Implications for a Novel Predictor of Alzheimer's Disease.
about
Multiple cognitive deficits during the transition to Alzheimer's diseaseArtificial neural networks allow the use of simultaneous measurements of Alzheimer disease markers for early detection of the disease.MRI and CSF studies in the early diagnosis of Alzheimer's disease.Biomarkers in the diagnosis of Alzheimer's disease: are we ready?The role of neuroimaging in mild cognitive impairment.Neuroimaging tools to rate regional atrophy, subcortical cerebrovascular disease, and regional cerebral blood flow and metabolism: consensus paper of the EADC.Covariance PET patterns in early Alzheimer's disease and subjects with cognitive impairment but no dementia: utility in group discrimination and correlations with functional performance(99m)Tc hexamethyl-propylene-aminoxime single-photon emission computed tomography prediction of conversion from mild cognitive impairment to Alzheimer disease.CSF tau and β-amyloid as biomarkers for mild cognitive impairment.A voxel based morphometry study on mild cognitive impairment.Brain perfusion correlates of visuoperceptual deficits in mild cognitive impairment and mild Alzheimer's disease.Pharmacology of Alzheimer's disease: appraisal and prospects.Fluid biomarkers in Alzheimer disease.Hypometabolism and altered cerebrospinal fluid markers in normal apolipoprotein E E4 carriers with subjective memory complaintsDo CSF total tau, phosphorylated tau, and beta-amyloid 42 help to predict progression of mild cognitive impairment to Alzheimer's disease? A systematic review and meta-analysis of the literature.Quantitative evaluation of Alzheimer's disease.Synapse stability in the precuneus early in the progression of Alzheimer's diseaseCSF tau and the CSF tau/ABeta ratio for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).Monoaminergic neuropathology in Alzheimer's disease.Increased oxidative damage in nuclear and mitochondrial DNA in mild cognitive impairment.Cerebrospinal fluid tau and Abeta42 concentrations in healthy subjects: delineation of reference intervals and their limitations.CSF biomarkers correlate with cerebral blood flow on SPECT in healthy elderly.Biomarkers for Alzheimer’s disease
P2860
Q22242620-240390D1-D22D-4D00-B428-3664AB466B9FQ24811064-F37B0B6F-826D-4D13-9B87-6876E1B2A24BQ30953178-BF56B645-A562-4AC1-8513-4DE2CE562D68Q31050728-E0AEFFC4-3AF8-49BF-9D9F-8A35612CF8B1Q31136940-60887240-DF86-420C-8CF3-A9C2CD5F5FF2Q33194112-B012F29B-37AC-460A-B24B-8B1C0E15B80CQ34518966-193CD2B4-EF31-4E74-92F5-8D67F6537FA5Q35010269-6328DE23-FDC6-485F-ABB9-CD2DDC479E44Q35236838-A7F8A859-B0A2-4E1E-8172-4052FF96F08DQ35483542-E15B1C2F-9A08-4CB1-9BBE-0139FD7D21F9Q35837451-1A83200A-A6B4-4B58-89E9-9D3A997C4478Q36071069-3A563E02-1296-4F33-90CB-97AB1040F195Q36186513-F15B649E-8A73-48B3-BD4B-04D33CB32823Q36661066-DD6837F3-743A-4855-9DAE-9EF086AF5844Q36948436-57E6A2F9-7D52-4D8C-999D-ABCEB1E14EF7Q37596431-8536D3B2-DDA8-4C62-A0C6-C666FF3DDB8DQ37724226-A70A9F1F-E4F6-4685-91A2-0655FC46C998Q38741683-9B1279B9-A3EE-41B9-9C09-08FA508DEB0AQ38809649-949C9030-047C-45BE-8BCA-AC253315E893Q46888735-0D2A57CB-93AD-4E0C-B67C-93246318B2BAQ47595482-32A874C6-DE30-4EC9-9A3F-A79F19E259CCQ48464443-95C2CE41-34EA-4F90-B210-3160C902C6CCQ57418134-6BAD6EC6-05D3-4BF4-B4AE-88AE53866D6C
P2860
Combined Analysis of CSF Tau Levels and [(123)I]Iodoamphetamine SPECT in Mild Cognitive Impairment: Implications for a Novel Predictor of Alzheimer's Disease.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Combined Analysis of CSF Tau Levels and [
@nl
Combined Analysis of CSF Tau L ...... dictor of Alzheimer's Disease.
@en
type
label
Combined Analysis of CSF Tau Levels and [
@nl
Combined Analysis of CSF Tau L ...... dictor of Alzheimer's Disease.
@en
prefLabel
Combined Analysis of CSF Tau Levels and [
@nl
Combined Analysis of CSF Tau L ...... dictor of Alzheimer's Disease.
@en
P2093
P1476
Combined Analysis of CSF Tau L ...... dictor of Alzheimer's Disease.
@en
P2093
Haruko Tanji
Hidetada Sasaki
Hiroshi Chiba
Hiroyuki Arai
Hisao Hirai
Makoto Higuchi
Masahiro Maruyama
Masatoshi Itoh
Takashi Seki
Toshifumi Matsui
P304
P356
10.1176/APPI.AJP.159.3.474
P407
P577
2002-03-01T00:00:00Z